There is a lack of transparency throughout the insulin supply chain. It is unclear precisely how the dollars flow and how much each intermediary profits.
ADA Issues White Paper Addressing Escalating Cost of Insulin posted first on https://www.youtube.com/dailyhealthpost/
No comments:
Post a Comment